陸振岡。2011。簡介美國基因轉殖水產生物安全評估規範-以AquAdvantage 鮭魚為例。農業生技產業季刊-水產生技26: 30- 35。 朱鴻鈞、陳政忻、余祁暐、孫智麗。2012。挪威鮭魚產業發展策略農業生技產業季刊-動物與水產生技31: 1-8。 郭金泉。2016。基改鮭魚面面觀。科技報導-時事評析409:7-9。 Aqua Bounty Technologies, Inc. 2010a. Environmental assessment for AquAdvantage Salmon-An atlantic salmon (Salmo salar L.) bearing a single copy of the stably integrated a-form of the opAFP-GHc2 gene construct at the a-locus in the EO-1a line. Submitted to the Center for Veterinary Medicine US Food and Drug Administration for public display. 1-84. Aqua Bounty Technologies, Inc. 2010b. AquAdvantage Salmon-Briefing packet. Submitted to the Center for Veterinary Medicine US Food and Drug Administration for Veterinary Medicine Advisory committee. 1-181. FDA. 2015. Guidance for Industry-Regulation of Genetically Engineered Animals Containing Heritable Recombinant DNA Constructs. #187 U.S. Department of Health and Human Services Food and Drug Administration Center for Veterinary. 1-28. Aqua Bounty Technologies, Inc.官方網站https://aquabounty.com/innovation/technology/; 2017年10月 FDA. 2017. Import Alert 99-40. US Food and Drug Administration. http://www.accessdata.fda.gov/cms_ia/importalert_1152.html; 2017年10月 |
基因改造生物知識平台 > 基因改造鮭魚 >